Enlivex Therapeutics Ltd. Made Big Gain
Enlivex Therapeutics Ltd. (ENLV:NASDAQ) jumped higher at $13.87, representing a gain of 22.7%. The stock got featured on our News Catalysts scanner on Tue 13 Oct 20 at 10:11 AM in the 'BIOTECH' category. From Mon 28 Sep 20, the stock recorded 60.00% Up Days and 63.64% Green Days
The stock spiked on Mon 05 Oct 20 at $15 with a volume of 7M+.
About Enlivex Therapeutics Ltd. (ENLV:NASDAQ)
Bioblast Pharma Ltd is an Israel-based development-stage biopharmaceutical company. The firm is focused on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic and metabolic diseases. It focuses on therapeutic platforms that offer solutions for several diseases that share a common pathophysiological mechanism, which are the functional changes that accompany a particular syndrome or disease. It also focuses on diseases with severe and debilitating manifestations.
Top 10 Gainers:
- Medigus Ltd. (MDGS:NASDAQ), 52.91%
- PEDEVCO Corp. (PED:NYSEMKT), 34.33%
- Blonder Tongue Laboratories, Inc. (BDR:NYSEMKT), 34.04%
- Aethlon Medical, Inc. (AEMD:NASDAQ), 33.11%
- J.Jill, Inc. (JILL:NYSE), 29.93%
- SOS (SOS:NYSE), 27.49%
- LRMR (LRMR:NASDAQ), 24.65%
- Onconova Therapeutics, Inc. (ONTX:NASDAQ), 24.46%
- Enlivex Therapeutics Ltd. (ENLV:NASDAQ), 22.74%
- Auris Medical Holding Ltd. (EARS:NASDAQ), 21.97%